Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top

Current Breast Cancer Reports

Issue 1/2022

Content (2 Articles)

Cytostatic Therapy Clinical Trial Report

Axillary Management: How Has Neoadjuvant Chemotherapy Changed Our Surgical Approach?

Mara A. Piltin, Judy C. Boughey

Breast Cancer Breast Cancer Management During the COVID-19 Pandemic (A Chagpar, Section Editor)

Breast Cancer Management During the COVID-19 Pandemic: the Radiation Oncology Perspective

Christin A. Knowlton

Dec 21
Issue: 4/2021
Jun 22
Issue: 2/2022

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits